adenosine monophosphate has been researched along with Furrow Keratitis in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hess, F; Pavan-Langston, D | 1 |
Falcon, MG; Jones, BR | 1 |
Geary, PA; North, RD; Pavan-Langston, D | 1 |
Centifanto, Y; Kaufman, HE; Trobe, JD; Varnell, E; Zam, ZS | 1 |
4 other study(ies) available for adenosine monophosphate and Furrow Keratitis
Article | Year |
---|---|
Ocular and systemic antiviral activity of vidarabine.
Topics: Adenosine Monophosphate; Animals; Chickenpox; Child; Child, Preschool; Corneal Injuries; Cricetinae; Cytomegalovirus Infections; Eye Diseases; Herpes Simplex; Herpes Zoster Ophthalmicus; Humans; Idoxuridine; Infant; Infant, Newborn; Infant, Newborn, Diseases; Keratitis, Dendritic; Rabbits; Smallpox; Vidarabine; Virus Diseases; Wound Healing | 1977 |
Herpes simplex keratitis: animal models to guide the selection and optimal delivery of antiviral chemotherapy.
Topics: Adenosine Monophosphate; Animals; Antiviral Agents; Cornea; Disease Models, Animal; Drug Evaluation, Preclinical; Hypoxanthines; Keratitis, Dendritic; Rabbits; Vidarabine | 1977 |
Ara AMP- a highly soluble new antiviral drug.
Topics: Adenosine Monophosphate; Animals; Iritis; Keratitis, Dendritic; Ointments; Ophthalmic Solutions; Purine Nucleosides; Rabbits; Solubility; Vidarabine | 1976 |
Anti-herpes activity of adenine arabinoside monophosphate.
Topics: Adenosine Monophosphate; Administration, Topical; Animals; Cytopathogenic Effect, Viral; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Herpesviridae; Keratitis, Dendritic; Purine Nucleosides; Rabbits; Vidarabine | 1976 |